May 24, 2021 / 03:00PM GMT
Kapil Gupta -
Good morning, and thank you for coming to the 2021 Virtual Global Healthcare Conference at UBS. My name is Kapil Gupta, and I'm happy to be your host for this session. Our next presenters will be John Nicols, who's the CEO; and Ross Taylor, the CFO, from Codexis. A Q&A session will follow immediately after the presentation. (Operator Instructions)
Let me now turn it over to John to take it from here. Thank you.
John J. Nicols - Codexis, Inc. - President, CEO & Director
Thank you, Kapil. Just a quick note that Ross and I will be making forward-looking statements today. And we encourage you to review the company's risk factors detailed in our most recent SEC filings.
So hi, I'm John Nicols. I'm President and CEO of Codexis. We, at Codexis, are focused on enzymes, their nearly unlimited potential to have a growing impact in our world, how Codexis is uniquely tapping into that potential, enabling better, healthier living and the enhanced sustainability of our planet.
Please advance to Slide 3. Britannica defines an enzyme
Codexis Inc at UBS Global Healthcare Virtual Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers